Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

There's a Lot to Like in AbbVie's Q3 Update
Motley Fool
Fri, 10/27/17 - 02:44 pm
Tags:
AbbVie, earnings, Humira, Imbruvica, Mavyret
AbbVie says Humira sales will balloon to $21 bln in 2020, shares rise
Yahoo/Reuters
Fri, 10/27/17 - 11:05 am
Tags:
AbbVie, Humira, earnings
AbbVie boasts a PhIII sweep for top psoriasis contender risankizumab, but it has lots of competition
Endpoints
Thu, 10/26/17 - 09:28 am
Tags:
AbbVie, psoriasis, risankizumab, Humira, Stelara, clinical trials
What’s driving the rapid growth of the top 20 biopharma companies in the world?
Endpoints
Wed, 10/25/17 - 11:24 am
Tags:
JNJ, Roche, Pfizer, Novartis, Merck, Serono, AbbVie, Sanofi, Amgen, Bayer, GSK
AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector
Endpoints
Tue, 10/24/17 - 09:10 am
Tags:
AbbVie, Alzheimer's disease, Alector, R&D
Can cancer charity efforts from Roche, Bristol, AbbVie and more boost pharma's reputation?
Fierce Pharma
Mon, 10/23/17 - 09:44 am
Tags:
charity, Roche, Bristol-Myers Squibb, AbbVie, cancer, reputation
What's next for biopharma Q3 earnings
Biopharma Dive
Sat, 10/21/17 - 09:50 pm
Tags:
earnings, Amgen, Bristol-Myers Squibb, Celgene, GSK, Gilead Sciences, AbbVie, Merck, Shire
Pfizer's Lyrica takes pharma TV spending crown from AbbVie's Humira for September
Fierce Pharma
Mon, 10/9/17 - 11:24 am
Tags:
Pfizer, Lyrica, AbbVie, Humira, drug ads, television ads
AbbVie hit with $140M verdict in second bellwether AndroGel case
Fierce Pharma
Fri, 10/6/17 - 11:39 am
Tags:
AbbVie, Androgel, heart attacks, testosterone
3 Big Pharma Stocks Set to Succeed
Motley Fool
Thu, 10/5/17 - 09:36 am
Tags:
AbbVie, Humira, patents, Allergan, Botox, Celgene, Revlimid
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
Tags:
biotech, Axovant Sciences, intepirdine, SAGE Therapeutics, brexanolone, AbbVie, risankizumab, Global Blood Therapeutics, GBT-440, DBV Technologies, Viaskin Peanut, Cytokinetics, Amicus Therapeutics, ATB200, Spark Therapeutics, Bluebird Bio, Revance Therapeutics, RT002
Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B
RAPS.org
Mon, 10/2/17 - 11:18 am
Tags:
AbbVie, Amgen, Humira, biosimilars, Medicare, Medicaid, CMS
AbbVie: Better Late Than Never
Barron's
Mon, 10/2/17 - 10:40 am
Tags:
AbbVie
Merck Hepatitis C exit could lift the space’s two remaining drugmakers
Marketwatch
Sun, 10/1/17 - 10:04 am
Tags:
Merck, hepatitis C, AbbVie, Gilead Sciences
How Good Is AbbVie's Humira Deal With Amgen?
Motley Fool
Fri, 09/29/17 - 10:06 am
Tags:
AbbVie, Amgen, Humira, biosimilars, Amjevita
Pharma's pricing pledges? Maybe they weren't such a good idea in the first place, experts say
Fierce Pharma
Thu, 09/28/17 - 09:55 am
Tags:
drug pricing, AbbVie
Under Amgen and AbbVie agreement, rival drug to AbbVie's Humira expected to launch in 2023
Marketwatch
Thu, 09/28/17 - 09:50 am
Tags:
Amgen, AbbVie, Humira, Amgevita, biosimilars, drug launches
What pledge? AbbVie executives may back off their vow to limit price hikes: report
Fierce Pharma
Mon, 09/25/17 - 07:34 pm
Tags:
AbbVie, drug pricing
AbbVie's Unfazed by the Risk of Generic Humira
Motley Fool
Mon, 09/25/17 - 09:45 am
Tags:
AbbVie, generics, Humira
AbbVie pairs up another ADC cancer drug with Bristol-Myers Squibb's Opdivo
Fierce Biotech
Sat, 09/23/17 - 10:02 am
Tags:
AbbVie, Bristol-Myers Squibb, Opdivo, ABBV-399, antibody-drug conjugate, non-small cell lung cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.